Thursday, February 27, 2020

Tuesday, February 25, 2020

New study associates intake of dairy milk with greater risk of breast cancer

Evidence suggests consistently drinking as little as one cup per day may increase rate of breast cancer up to 50%



Dairy, soy and risk of breast cancer: Those confounded milks, published in the International Journal of Epidemiology, found that even relatively moderate amounts of dairy milk consumption can increase women's risk of breast cancer -- up to 80% depending on the amount consumed.

"Consuming as little as 1/4 to 1/3 cup of dairy milk per day was associated with an increased risk of breast cancer of 30%," Fraser said. "By drinking up to one cup per day, the associated risk went up to 50%, and for those drinking two to three cups per day, the risk increased further to 70% to 80%."
Current U.S. Dietary guidelines recommend three cups of milk per day. "Evidence from this study suggests that people should view that recommendation with caution," Fraser said.
Dietary intakes of nearly 53,000 North American women were evaluated for the study, all of whom were initially free of cancer and were followed for nearly eight years. Dietary intakes were estimated from food frequency questionnaires (FFQ), also repeated 24 hour recalls, and a baseline questionnaire had questions about demographics, family history of breast cancer, physical activity, alcohol consumption, hormonal and other medication use, breast cancer screening, and reproductive and gynecological history.
By the end of the study period, there were 1,057 new breast cancer cases during follow-up. No clear associations were found between soy products and breast cancer, independent of dairy. But, when compared to low or no milk consumption, higher intakes of dairy calories and dairy milk were associated with greater risk of breast cancer, independent of soy intake. Fraser noted that the results had minimal variation when comparing intake of full fat versus reduced or nonfat milks; there were no important associations noted with cheese and yogurt.
"However," he said, "dairy foods, especially milk, were associated with increased risk, and the data predicted a marked reduction in risk associated with substituting soymilk for dairy milk. This raises the possibility that dairy-alternate milks may be an optimal choice."
A hazardous effect of dairy is consistent with the recent AHS-2 report suggesting that vegans but not lacto-ovo-vegetarians experienced less breast cancer than non-vegetarians.
Fraser said the possible reasons for these associations between breast cancer and dairy milk may be the sex hormone content of dairy milk, as the cows are of course lactating, and often about 75% of the dairy herd is pregnant. Breast cancer in women is a hormone-responsive cancer. Further, intake of dairy and other animal proteins in some reports is also associated with higher blood levels of a hormone, insulin-like growth factor-1 (IGF-1), which is thought to promote certain cancers.
"Dairy milk does have some positive nutritional qualities," Fraser said, "but these need to be balanced against other possible, less helpful effects. This work suggests the urgent need for further research."

Thursday, February 20, 2020

Scientists breach brain barriers to attack tumors

The brain is equipped with barriers designed to keep out dangerous pathogens. Researchers have now found a novel way to circumvent the brain's natural defenses when they're counterproductive.


Scientists find ally in fight against brain tumors: Ebola

Glioblastomas are relentless, hard-to-treat, and often lethal brain tumors. Scientists have enlisted a most unlikely ally in efforts to treat this form of cancer -- elements of the Ebola virus.


Dozens of non-oncology drugs can kill cancer cells

Researchers tested approximately 4,518 drug compounds on 578 human cancer cell lines and found nearly 50 that have previously unrecognized anti-cancer activity. These drugs have been used to treat conditions such as diabetes, inflammation, alcoholism, and even arthritis in dogs. The findings suggest a possible way to accelerate the development of new cancer drugs or repurpose existing drugs to treat cancer.


Cancer-causing culprits will be caught by their DNA fingerprints

Causes of cancer are being catalogued by a huge international study revealing the genetic fingerprints of DNA-damaging processes that drive cancer development. This detailed list of genetic fingerprints will provide clues how each cancer developed. This will help scientists search for previously unknown causes of cancer, leading to better information for prevention strategies, and help signpost new directions for cancer diagnosis and treatments.

The recent advancements in cancer are going to be discussed in this "6th Edition of International Conference on Clinical Oncology".


Thursday, February 13, 2020

6th Edition of International Conference on Clinical Oncology

About Conference


With zeal, we are glad to announce the 6th Edition of International Conference on Clinical Oncology (Clinical Oncology 2020) organized in collaboration with generous support and cooperation from enthusiastic academicians and Editorial Board Members. Clinical Oncology 2020 aims at sharing new ideas and technologies amongst the professionals, industrialists and students from research areas of Oncology. As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting-edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.
Clinical Oncology 2020 Conference is a novel discussion to unite overall recognized scholastic Researchers, Public wellbeing experts, Scientists, Academic researchers, Industry specialists, Scholars in the field of OncologyHaematologySurgeryNursingRadiologyPaediatricsAdvocacy, etc., to exchange about the state of the Research and Development.
Why Should Attend?
The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We likewise incorporate talks on most recent methodologies for concentrating these biological inquiries.

Thursday, February 6, 2020

Highlights of Clinical Oncology 2020